Authors’ reply: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru.. Falster

ation and management of dyslipidemia in human immuno- defi ciency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medicine Association

Evaluation of Viral Resistance to Reverse Transcriptase Inhibitors (RTI) in HIV-1- Infected Patients Before and After 6 Months of Single or Double Antiretroviral Therapy..

Objective : To evaluate the prevalence of and the associated factors for metabolic syndrome (MS) among Latin American HIV-infected patients receiving antiretroviral therapy (ART)

Tuberculosis is one of the leading causes of development of Immune reconstitution inflamma- tory syndrome (IRIS) in HIV patients receiving antiretroviral therapy (ART).. Objective: To

active antiretroviral therapy are at higher risk of cardiovascular diseases than human immunodeficiency virus infected patients not receiving highly active antiretroviral therapy,

The use of antiretroviral therapy (ART) in these patients reduces the risk of developing active TB [32,33,34], being associated in HIV-infected TB patients with higher rates

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV- infected patients after the introduction of highly active antiretroviral therapy. Euro SIDA Study